Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Freshpet Inc CS
(NQ:
FRPT
)
152.05
+18.36 (+13.73%)
Streaming Delayed Price
Updated: 1:48 PM EST, Nov 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Freshpet Inc CS
< Previous
1
2
3
4
5
6
7
Next >
Earnings Scheduled For February 27, 2023
February 27, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.14 per share on revenue of $505.61 million.
Via
Benzinga
Earnings Preview For Freshpet
February 24, 2023
Via
Benzinga
Analyst Ratings for Freshpet
December 07, 2022
Via
Benzinga
Analysts and Executives Converge February 2nd at the 30th Annual Emerald Groundhog Day Investment Forum
January 26, 2023
From
Emerald Asset Management PA, LLC
Via
Business Wire
Freshpet's Visibility Of Margin Improvement Makes This Analyst Remain Bullish On The Stock
January 11, 2023
Via
Benzinga
Chewy Stock: Bull vs. Bear
December 21, 2022
Is the pet products retailer a buy? See what the bulls and bears have to say.
Via
The Motley Fool
Lyft Price Target Cut By 56%; Plus Piper Sandler Sees $61 For Five9
November 08, 2022
Evercore ISI Group cut the price target on Lyft, Inc. (NASDAQ: LYFT) from $41 to $18. Lyft shares fell 17.1% to $11.72 on Tuesday.
Via
Benzinga
What 13 Analyst Ratings Have To Say About Freshpet
November 03, 2022
Within the last quarter, Freshpet (NASDAQ:FRPT) has observed the following analyst ratings:
Via
Benzinga
Expert Ratings for Freshpet
November 03, 2022
Within the last quarter, Freshpet (NASDAQ:FRPT) has observed the following analyst ratings:
Via
Benzinga
Freshpet (FRPT) Q3 2022 Earnings Call Transcript
November 01, 2022
FRPT earnings call for the period ending September 30, 2022.
Via
The Motley Fool
What 10 Analyst Ratings Have To Say About Freshpet
September 08, 2022
Analysts have provided the following ratings for Freshpet (NASDAQ:FRPT) within the last quarter:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 3, 2022
November 03, 2022
Upgrades
Via
Benzinga
Freshpet: A Fresh Time To Buy Into This Growth Story?
November 02, 2022
Freshpet is pulling back after a weaker-than-expected report but there are signs the stock is bottoming and expected improvements in the margin is coming.
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
Jim Cramer Says Freshpet Is 'Too Expensive,' This Stock Has 'A Better Pet Food Division'
October 19, 2022
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Freshpet, Inc. (NASDAQ: FRPT) is "too expensive." He said General Mills, Inc.
Via
Benzinga
Freshpet Finance Chief Steps Down; Co. Reaffirms FY22 Outlook
September 07, 2022
Via
Benzinga
Analyst Ratings for Freshpet
August 09, 2022
Within the last quarter, Freshpet (NASDAQ:FRPT) has observed the following analyst ratings:
Via
Benzinga
Short Interest Sector Focus: Consumer Defensive Sector
October 12, 2022
As of the close of business on Tuesday, 10/11, we captured the Top 10 Highest Short Interest % stocks within the Consumer Defensive Sector. The average short interest for stocks within the Consumer...
Via
Benzinga
Expert Ratings for Freshpet
September 30, 2022
Over the past 3 months, 11 analysts have published their opinion on Freshpet (NASDAQ:FRPT) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
Where Freshpet Stands With Analysts
September 30, 2022
Over the past 3 months, 11 analysts have published their opinion on Freshpet (NASDAQ:FRPT) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 30, 2022
September 30, 2022
Upgrades
Via
Benzinga
Will Activist Investors Change the Game for Freshpet (FRPT) Stock?
September 23, 2022
Freshpet (FRPT) stock is rallying on Friday as traders look to news of an activist stake in the company as a potential positive.
Via
InvestorPlace
Why Avenue Therapeutics Shares Surged Around 106%; Here Are 87 Biggest Movers From Yesterday
September 23, 2022
Gainers
Via
Benzinga
7 Kim Kardashian Stocks to Buy
September 14, 2022
These Kim Kardashian Stocks to Buy are what's Kimmie's new equity firm is all about. There's no reason she won't succeed here as well.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For September 8, 2022
September 08, 2022
Via
Benzinga
Short Interest Sector Focus: Consumer Defensive Sector
August 25, 2022
As of the close of business on Wednesday, 8/25, we captured the Top 10 Highest Short Interest % stocks within the Consumer Defensive Sector. The average short interest for stocks within the Consumer...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 18, 2022
August 18, 2022
Via
Benzinga
Your Pet Or Car? When Times Got Rough, Consumers Made A Tough Choice This Summer
August 15, 2022
Freshpet Inc’s (NASDAQ: FRPT) second-quarter earnings report offered great insight into the current macroeconomic trends currently affecting the pockets of Americans.
Via
Benzinga
Micron Technology, Novavax, CarGurus And Some Other Big Losers From Tuesday
August 10, 2022
U.S. stocks closed lower, with the Nasdaq dropping 150 points on Tuesday. Here is the list of some big stocks moving lower in the previous session.
Via
Benzinga
Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday
August 10, 2022
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method.
Via
Benzinga
Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session
August 09, 2022
Gainers Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD....
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.